Invasive Technologies
Invasive Technologies is an unverified brand name for which no reliable commercial evidence was supplied.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
The supplied evidence does not contain any information about a company, product brand, platform, retailer, or trademark operating under the name "Invasive Technologies." The two source snippets are art-world news items: one concerns the appointment of Martin Clark as CEO and Director of Towner in Eastbourne, and the other is a personal essay about custom Blythe dolls. Neither mentions Invasive Technologies, its products, ownership, headquarters, or history. Because no official-site content, Wikipedia entry, or other brand-sense evidence was provided, this dossier cannot responsibly describe what Invasive Technologies sells, where it operates, who owns it, or when it was founded. The name may refer to a technology company, a security or software vendor, or another commercial venture, but none of that is supported by the evidence at hand. Any such details would be speculation and are therefore omitted. This entry is flagged for review. It should be revisited only when verifiable brand-sense sources — an official website, a corporate registry filing, a Wikipedia article about the company, or reputable trade press — become available. Until then, the record should be treated as an unresolved name rather than an established commercial brand.
Recent events
Reported
SCTIMST and Invasive Technologies launch Chitracore drug-eluting stent[3]
An indigenous drug-eluting stent named Chitracore, developed by scientists and cardiologists at the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), was launched at the annual conference of the Interventional Cardiology Council of Kerala in Thiruvananthapuram. The stent was unveiled by Invasive Technologies, which received the technology from SCTIMST through a technology-transfer arrangement and manufactures it in partnership with SCTIMST. Chitracore is an everolimus-eluting cobalt chromium stent priced in line with the National Pharmaceutical Pricing Authority ceiling price.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/invasive-technologies · Editorial policy · How profiles are compiled